Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 37867445)

  • 1. Fraxetin inhibits proliferation and induces apoptosis of bladder cancer through the Akt pathway in vitro and in vivo.
    Weng M; Deng Z; Huang S; Lin X; Xu N; Sun X; Wu W; Lu J; Wang D
    J Biochem Mol Toxicol; 2024 Jan; 38(1):e23556. PubMed ID: 37867445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fraxetin down-regulates polo-like kinase 4 (PLK4) to inhibit proliferation, migration and invasion of prostate cancer cells through the phosphatidylinositol 3-kinase (PI3K)/protein kinase B (Akt) pathway.
    Ma Z; Sun Y; Peng W
    Bioengineered; 2022 Apr; 13(4):9345-9356. PubMed ID: 35387563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fraxetin inhibits the growth of colon adenocarcinoma cells via the Janus kinase 2/signal transducer and activator of transcription 3 signalling pathway.
    Ren S; Xing Y; Wang C; Jiang F; Liu G; Li Z; Jiang T; Zhu Y; Piao D
    Int J Biochem Cell Biol; 2020 Aug; 125():105777. PubMed ID: 32504672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fraxetin suppresses reactive oxygen species-dependent autophagy by the PI3K/Akt pathway to inhibit isoflurane-induced neurotoxicity in hippocampal neuronal cells.
    Zhang T; Zhou B; Sun J; Song J; Nie L; Zhu K
    J Appl Toxicol; 2022 Apr; 42(4):617-628. PubMed ID: 34553399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploring the mechanism of fraxetin against acute myeloid leukemia through cell experiments and network pharmacology.
    Fang T; Liu L; Liu W
    BMC Complement Med Ther; 2024 Jun; 24(1):226. PubMed ID: 38858650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Flavagline analog FL3 induces cell cycle arrest in urothelial carcinoma cell of the bladder by inhibiting the Akt/PHB interaction to activate the GADD45α pathway.
    Yuan G; Chen X; Liu Z; Wei W; Shu Q; Abou-Hamdan H; Jiang L; Li X; Chen R; Désaubry L; Zhou F; Xie D
    J Exp Clin Cancer Res; 2018 Feb; 37(1):21. PubMed ID: 29415747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PPARγ activation serves as therapeutic strategy against bladder cancer via inhibiting PI3K-Akt signaling pathway.
    Lv S; Wang W; Wang H; Zhu Y; Lei C
    BMC Cancer; 2019 Mar; 19(1):204. PubMed ID: 30845932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metformin exerts an antitumor effect by inhibiting bladder cancer cell migration and growth, and promoting apoptosis through the PI3K/AKT/mTOR pathway.
    Shen Z; Xue D; Wang K; Zhang F; Shi J; Jia B; Yang D; Zhang Q; Zhang S; Jiang H; Luo D; Li X; Zhong Q; Zhang J; Peng Z; Han Y; Sima C; He X; Hao L
    BMC Urol; 2022 May; 22(1):79. PubMed ID: 35610639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Relationship between the inhibitory effect of fraxetin on breast cancer and estrogen signaling pathway].
    Huo HN; Xie KP; Wang LM; Jiang Y; Zou W; Xie MJ
    Sheng Li Xue Bao; 2013 Jun; 65(3):323-8. PubMed ID: 23788190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Andrographolide Inhibits Proliferation and Promotes Apoptosis in Bladder Cancer Cells by Interfering with NF- κ B and PI3K/AKT Signaling In Vitro and In Vivo.
    Xuan L; Hu JH; Bi R; Liu SQ; Wang CX
    Chin J Integr Med; 2022 Apr; 28(4):349-356. PubMed ID: 35048242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Role of Specificity Protein 1 (SP1) in Bladder Cancer Progression through PTEN-Mediated AKT/mTOR Pathway.
    Chen Z
    Urol Int; 2023; 107(9):848-856. PubMed ID: 37666229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Knockdown of TRIM26 inhibits the proliferation, migration and invasion of bladder cancer cells through the Akt/GSK3β/β-catenin pathway.
    Xie X; Li H; Pan J; Han X
    Chem Biol Interact; 2021 Mar; 337():109366. PubMed ID: 33549581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SC66 inhibits the proliferation and induces apoptosis of human bladder cancer cells by targeting the AKT/β-catenin pathway.
    Chen W; Zhao S; Yu W; Rao T; Ruan Y; Zhu S; Xia Y; Song H; Cheng F
    J Cell Mol Med; 2021 Nov; 25(22):10684-10697. PubMed ID: 34687144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isofraxidin inhibited proliferation and induced apoptosis via blockage of Akt pathway in human colorectal cancer cells.
    Shen P; Wang HG; Li MM; Ma QY; Zhou CW; Pan F; Xie R
    Biomed Pharmacother; 2017 Aug; 92():78-85. PubMed ID: 28531803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long non-coding RNA HULC promotes bladder cancer cells proliferation but inhibits apoptosis via regulation of ZIC2 and PI3K/AKT signaling pathway.
    Wang J; Ma W; Liu Y
    Cancer Biomark; 2017 Dec; 20(4):425-434. PubMed ID: 28946549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leflunomide Inhibits Proliferation and Induces Apoptosis via Suppressing Autophagy and PI3K/Akt Signaling Pathway in Human Bladder Cancer Cells.
    Cheng L; Wang H; Wang Z; Huang H; Zhuo D; Lin J
    Drug Des Devel Ther; 2020; 14():1897-1908. PubMed ID: 32546957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sialidase NEU1 suppresses progression of human bladder cancer cells by inhibiting fibronectin-integrin α5β1 interaction and Akt signaling pathway.
    Zhou X; Zhai Y; Liu C; Yang G; Guo J; Li G; Sun C; Qi X; Li X; Guan F
    Cell Commun Signal; 2020 Mar; 18(1):44. PubMed ID: 32164705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-608 inhibits proliferation of bladder cancer via AKT/FOXO3a signaling pathway.
    Liang Z; Wang X; Xu X; Xie B; Ji A; Meng S; Li S; Zhu Y; Wu J; Hu Z; Lin Y; Zheng X; Xie L; Liu B
    Mol Cancer; 2017 May; 16(1):96. PubMed ID: 28549468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isoquercitrin inhibits bladder cancer progression in vivo and in vitro by regulating the PI3K/Akt and PKC signaling pathways.
    Chen F; Chen X; Yang D; Che X; Wang J; Li X; Zhang Z; Wang Q; Zheng W; Wang L; Wang X; Song X
    Oncol Rep; 2016 Jul; 36(1):165-72. PubMed ID: 27177091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fraxetin induces cell death in colon cancer cells via mitochondria dysfunction and enhances therapeutic effects in 5-fluorouracil resistant cells.
    Lee M; Yang C; Park S; Song G; Lim W
    J Cell Biochem; 2022 Feb; 123(2):469-480. PubMed ID: 34816480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.